Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases

Hum Pathol. 1989 Sep;20(9):832-8. doi: 10.1016/0046-8177(89)90093-2.

Abstract

The immunoreactivity of two monoclonal antibodies, CO17-1A (recognizing 17-1A antigen) and B72.3 (recognizing TAG-72), was examined in pancreatic tissues from individuals without pancreatic disease and from those with benign and malignant pancreatic disease. 17-1A antigen was found in all cells in the normal tissue, whereas TAG-72 was present in the duct cells in only one case. Both antigens were present in benign diseases; however, in some cells and in some conditions, TAG-72 was significantly less common (P less than .01 to .001) than 17-1A antigen. In pancreatic cancer, 17-1A antigen was present in 87% of cases and TAG-72 antigen was present in 92% of cases. The results indicate that B72.3 is more specific to pancreatic cancer than C017-1A.

MeSH terms

  • Acute Disease
  • Adenocarcinoma / analysis
  • Adenocarcinoma / pathology*
  • Antibodies, Monoclonal*
  • Antigens, Neoplasm / analysis*
  • Biomarkers, Tumor / analysis*
  • Chronic Disease
  • Glycoproteins / analysis*
  • Humans
  • Immunoenzyme Techniques
  • Pancreas / analysis
  • Pancreas / cytology*
  • Pancreas / pathology
  • Pancreatic Neoplasms / analysis
  • Pancreatic Neoplasms / pathology*
  • Pancreatitis / pathology*
  • Reference Values

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Glycoproteins
  • carcinoma-associated antigen 17-1A
  • tumor-associated antigen 72